Hunan Er-Kang Pharmaceutical Co. Ltd. | Ownership
Companies that own Hunan Er-Kang Pharmaceutical Co. Ltd.
Shaanxi International Trust Co. Ltd. (Invt Mgmt)
87,671,000
8.09%
87,671,000
2%
09/30/2017
China Post & Capital Fund Management Co., Ltd.
79,560,819
7.34%
-42,139,249
1.9%
09/30/2017
China Asset Management Co., Ltd.
49,829,085
4.59%
2,728,452
0.13%
09/30/2017
China Investment Corp. (Investment Management)
34,689,600
3.2%
0
0.05%
09/30/2017
The Vanguard Group, Inc.
1,676,979
0.16%
0
0%
07/31/2018
GF Fund Management Co., Ltd.
500,332
0.05%
-336,401
0%
12/31/2017
Da Cheng Fund Management Co., Ltd.
181,604
0.02%
-47,900
0%
12/31/2017
China Southern Asset Management Co., Ltd.
46,400
0%
-202,800
0%
12/31/2017
E Fund Management Co., Ltd.
33,918
0%
-3,076,791
0%
12/31/2017
Golden Eagle Asset Management Co., Ltd.
25,500
0%
25,500
0%
06/30/2017
| Address |
Liuyang Economic & Development Zone
Changsha Hunan 410331
China
|
|
Employees
|
- |
| Website |
http://www.hnerkang.com |
| Updated |
07/08/2019 |
| Hunan Er-Kang Pharmaceutical Co., Ltd. engages in the research and development, production and sale of pharmaceutical products. It offers pharmaceutical excipients, active pharmaceutical ingredients (API) and pharmaceutical preparation. The pharmaceutical excipients produce glycerol, medicinal alcohol, propylene glycol, medicinal sodium hydroxide and medical sucrose. |
